Osmind Raises $2M Seed Round to Revolutionize Mental Health by Empowering Mental Health Patients, Clinicians, and Researchers

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- #generalcatalyst--Osmind, a healthcare technology startup providing software and clinical insights for mental health, announced today that it raised $2M in seed funding. The fundraising round was led by General Catalyst, with participation from What If Ventures, 20|20 Fund, Jeffrey Leiden MD, PhD (Executive Chairman of Vertex Pharmaceuticals), Alice Zhang (co-founder and CEO of Verge Genomics), and a number of other prominent healthcare executives. Osmind is also backed by

Click to view original post